drugset / Trial / NCT02582047

Influenza Vaccine and Pneumococcal Vaccine

NCT02582047

Phase 4 Completed 224 enrolled Korea University Guro Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Previous studies have demonstrated the immunogenicity and safety of the co-administration of the trivalent inactivated influenza vaccine (IIV3) with the polysaccharide pneumococcal vaccine (PPV) or pneumococcal conjugate vaccine (PCV). However, there is no direct comparison study that evaluates the immunogenicity and safety of IIV3 given concomitantly with PCV13 or PPV23 in the elderly. This study is intended to compare the immunogenicity and safety of concomitant administration in the elderly subjects.

Timeline

Start
2012-10
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator GCflu Unknown
Comparator Pneumovax 23 Vaccine
Comparator Prevnar 13 Vaccine